Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amitriptyline for Chronic Laryngitis
NCT02552225Phase 3Terminated
- Sponsor
- Boston Medical Center
- Start
- Apr 2016
- Primary completion
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of amitriptyline in laryngitis, sponsored by Boston Medical Center. Started Apr 2016; status: terminated.
02
Drugs
amitriptyline
03
Conditions
laryngitis
Beyond the preview
Go deeper on NCT02552225.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02552225.